Zobrick is a combination of Cefoperazone, a third-generation cephalosporin, and Sulbactam, a β-lactamase inhibitor. This synergistic combination is formulated in a fixed ratio to effectively treat bacterial infections, especially those caused by β-lactamase-producing resistant pathogens.
